Novel Antiviral Strategies: Targeting Host Factors to Combat Emerging Viral Infections

Maria Garcia^*
*Correspondence: Maria Garcia, Department of Life Science, Atlantic Technological University, F91 YW50 Sligo, Ireland, Email:

Introduction

Emerging viral infections pose significant threats to global health, as demonstrated by recent outbreaks such as Ebola, Zika, and most notably, the ongoing COVID-19 pandemic caused by the SARS-CoV-2 virus. Traditional antiviral approaches primarily focus on directly targeting viral components, such as viral proteins or their replication machinery. However, the rapid emergence of drug-resistant viruses and the challenges associated with developing specific antiviral agents have necessitated the exploration of alternative strategies. This review aims to explore the concept of novel antiviral strategies that target host factors, which play critical roles in viral infection and replication. By focusing on host factors, these strategies offer the potential for broad-spectrum antiviral activity and enhanced effectiveness against emerging viral infections [1].

Description

Host factors are proteins, pathways, or processes within host cells that viruses exploit for their replication, assembly, and spread. Viruses rely on specific host factors to enter cells, replicate their genetic material, and evade immune responses. Understanding the interaction between viruses and host factors provides valuable insights into potential targets for antiviral intervention [2]. Novel antiviral strategies aim to disrupt the interaction between viruses and host factors, thereby preventing viral replication and spread. By targeting host factors, these strategies offer several advantages, including broad-spectrum activity against multiple viruses, reduced risk of viral resistance, and potential efficacy against emerging viral infections for which specific antiviral agents are not yet available [3].

Numerous host factors have been identified as potential targets for antiviral intervention. These include cellular receptors used by viruses for entry, intracellular signaling pathways hijacked by viruses for replication, and host factors involved in viral assembly and release. By developing inhibitors or modulators that specifically target these host factors, it is possible to disrupt the viral life cycle and inhibit viral replication [4]. Novel antiviral strategies that target host factors provide a promising avenue for combating emerging viral infections. By focusing on host factors, these strategies offer the potential for broad-spectrum antiviral activity and enhanced efficacy against viruses that rapidly evolve and develop drug resistance. Targeting host factors can disrupt critical interactions between viruses and host cells, preventing viral entry, replication, and spread.

While the development of host-targeted antiviral therapies presents exciting opportunities, several challenges need to be addressed. These include identifying suitable host factors with minimal impact on normal cellular functions, optimizing the selectivity and efficacy of inhibitors or modulators, and ensuring their safety for clinical use. Collaboration between virologists, immunologists, and drug discovery experts is crucial for the successful development and translation of these novel antiviral strategies [5].

Conclusion

In conclusion, targeting host factors represents a promising approach to combat emerging viral infections. By disrupting key interactions between viruses and host cells, these strategies offer the potential for broad-spectrum antiviral activity and improved effectiveness against evolving viruses. Continued research and development in this field have the potential to revolutionize antiviral therapy and enhance our ability to control and prevent future viral outbreaks.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Goswami, Roshan, Despo Chatzikleanthous, Gustavo Lou and Michela Brazzoli, et al. "Mannosylation of LNP results in improved potency for self-amplifying RNA (SAM) vaccines." ACS Infect Dis 5 (2019): 1546-1558.

Google Scholar, Crossref, Indexed at

2. El-Sagheer, Afaf H., and Tom Brown. "Efficient RNA synthesis by in vitro transcription of a triazole-modified DNA template." Chem Comm 47 (2011): 12057-12058.

Google Scholar, Crossref, Indexed at

3. Anderson, Bart R., Hiromi Muramatsu, Subba R. Nallagatla and Katalin Karikó, et al. "Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation." Nucleic Acids Res 38 (2010): 5884-5892.

Google Scholar, Crossref, Indexed at

4. Moon, Stephanie L., and Jeffrey Wilusz. "In vitro transcription of modified RNAs." Recombinant Vitro RNA Synthesis: Methods Protoco (2012): 171-180.

Google Scholar, Crossref, Indexed at

5. Pardi, Norbert, Michael J. Hogan, Frederick W. Porter and Drew Weissman, et al. "mRNA vaccines—a new era in vaccinology." Nat Rev Drug Discov 17 (2018): 261-279.

Google Scholar, Crossref, Indexed at